NCR to Present at Upcoming Investor Conferences
Get Alerts NCR Hot Sheet
Join SI Premium – FREE
ATLANTA--(BUSINESS WIRE)-- NCR Corporation (NYSE: NCR), a global enterprise technology provider for the banking, retail and hospitality industries, today announced that President and Chief Executive Officer Michael D. Hayford will present to investors at the RBC Capital Markets Technology, Internet, Media and Telecommunications Virtual Conference on Nov. 17, 2020 at 1:20 p.m. Eastern Time.
Chief Financial Officer Tim Oliver will present to investors at the Bank of America Leveraged Finance Virtual Conference on Nov. 30, 2020, at 8:15 a.m. Eastern Time.
Additionally, Tim Oliver will present to investors at the Wells Fargo Securities Virtual TMT Summit on Dec. 1, 2020 at 1:20 p.m. Eastern Time.
A live webcast and replay of the sessions will be available in the Investor Relations section of NCR.com (investor.ncr.com) for 90 days following the sessions.
About NCR Corporation
NCR Corporation (NYSE: NCR) is a leading software- and services-led enterprise provider in the financial, retail and hospitality industries. NCR is headquartered in Atlanta, Ga., with 36,000 employees and does business in 180 countries. NCR is a trademark of NCR Corporation in the United States and other countries.
Web site: www.ncr.com
Twitter: @NCRCorporation
Facebook: www.facebook.com/ncrcorp
LinkedIn: www.linkedin.com/company/ncr-corporation
YouTube: www.youtube.com/user/ncrcorporation
View source version on businesswire.com: https://www.businesswire.com/news/home/20201112006038/en/
Investor Contact
Michael Nelson
NCR Corporation
678-808-6995
[email protected]
Media Contact
Scott Sykes
NCR Corporation
212-589-8428
[email protected]
Source: NCR Corporation
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 84% of Singapore Consumers Say Age-Gated Content Can Harm Minors, Putting Pressure on Platforms to Strengthen Age Assurance
- Sangfor Launches New Whitepaper Featuring GartnerĀ® Research on VMware Modernization
- ArkBio Announces China IND Approval for its Antiviral Drug-Fc Conjugate (AFC) Candidate AK0406 for Influenza Prophylaxis
Create E-mail Alert Related Categories
Business Wire, Press ReleasesRelated Entities
RBC Capital, Twitter, Wells Fargo, BofA/Merrill LynchSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share